microRNA 3179-1 (MIR3179-1)

microRNA 3179-1 is a human microRNA gene in the non-coding RNA category. Like other miRNAs, MIR3179-1 itself represents a short (20-24 nucleotide) RNA transcript that modulates mRNA stability or translation by targeting sequences—in this case, its exact targets remain largely uncharacterized[4]. Related functional work has shown that miR-3179 (the family) can exert enhancer-associated activities in co-regulated chromosomal regions, including upregulation of neighboring genes via chromatin activation signatures, though this has been established more robustly for other miRNAs and only as part of global enhancer-miRNA studies[2]. There is currently no published evidence identifying MIR3179-1 as a receptor, enzyme, transporter, or other target class, and it is not recognized as a direct therapeutic target. No clinically approved drugs or investigational agents specifically interact with MIR3179-1[4][2]. The gene is referenced in genomic databases (such as GeneCards) as being part of the broad miRNA family with canonical roles in post-transcriptional gene regulation but without specific disease attributions[4]. Detailed functions (targets, effects in disease, druggability) have not been established for MIR3179-1 in the scientific literature to date. Summary of limitations: - There is minimal published, experimentally confirmed functional characterization for MIR3179-1. - No evidence supports a labeling as a drug target, disease gene, or biomarker. - Most descriptions are generic to the miRNA family, not this individual microRNA. If you require a standardized data record for structured analysis, MIR3179-1 should be considered an uncharacterized human microRNA gene with currently unknown clinical or therapeutic relevance.

Other names

hsa-mir-3179-1MIR3179-1miR-3179-1

Not established for this specific miRNA